Background: Gestational diabetes mellitus (GDM) is associated with maternal and fetal complications. Specific outcomes in previous pregnancies are considered as risk factors for GDM in the consecutive pregnancies. The aim of this study was to evaluate the pregravid risk factors of GDM in multigravid women.
Introduction
Gestational diabetes mellitus (GDM) is defined as diabetes which is first discovered or has its onset during pregnancy. The prevalence of this disease varies between populations from 1% to 16% because of the differences in the populations and the diagnostic methods used. [1] [2] [3] In Iran, according to separate studies by Hossein-nezhad and Khooshideh, GDM prevalence was estimated 4-8.9%.
4-6 GDM is not only associated with maternal complications but also with fetal problems that could impose a great burden on health systems. Maternal complications include pregnancy induced hypertension and preeclampsia, premature ruptures of membranes, preterm birth and the increased risk of cesarean section. Affected women are in an increased risk for diabetes in the following years. [7] [8] [9] The fetuses whose mothers have experienced gestational diabetes mellitus are at increased risk of macrosomia and being large for gestational age which put them in the risk of birth trauma, shoulder distocia, neonatal hypoglycemia and neonatal death. 10 In medical sciences, identification of risk factors is very important. If we can determine the risk factors, we can identify the population at risk and design some interventions to prevent the disease. Moreover, if the disease established, we can diagnose it in early stages and prevent its progression and decrease its complications. There are lots of studies which have evaluated the common risk factors of GDM. The obesity before pregnancy and high weight gain during pregnancy, family history of diabetes mellitus, high maternal age, some ethnic backgrounds and previous diagnosis of gestational diabetes, impaired fasting glucose or impaired glucose tolerance predispose women to GDM. 4, [11] [12] [13] In this study, we evaluated the previous history of those multiparous women with no previous history of overt or gestational diabetes mellitus and compared them with the healthy multiparous control group to find potential risk factors which are associated with GDM.
Materials and Methods
We conducted a retrospective cross sectional study using the medical records of pregnant women came to Antenatal Clinic of Imam Khomeini Hospital, the largest teaching hospital of Tehran University of Medical Sciences in Tehran, Iran, over a period of two years. The patient's files were randomly selected. Primigravid women and those with previous history of overt diabetes or GDM were excluded from the study. The test group was consisted of 114 multiparous pregnant women with first diagnosis of GDM and the control group was consisted of 113 pregnant healthy ones. We used modified criteria of Carpenter and Coustan for screening. Women without previously diagnosed diabetes underwent fifty gram nonfasting one hour glucose challenge test between 24 to 28 weeks of gestation. Women who had a blood sugar more than 140 mg/dl underwent a 100-gram three hour glucose tolerance test after three days of a high carbohydrate diet. If two or more of the plasma glucose measurements meet or exceed the following thresholds, the diagnosis of GDM was confirmed: fasting plasma glucose=95 mg/dl, one hour plasma glucose=180 mg/dl, two hour plasma glucose=155 mg/dl and three hour plasma glucose=140 mg/dl.
3
Diagnosis of hypothyroidism was made by evaluating the TSH and free T4 levels which were measured at the central laboratory of the hospital. Reference range for TSH was 0.35-4 mU/I for this laboratory. Women with TSH more than 4 and free T4 below the lower limit were considered to have hypothyroidism. Statistical analysis was performed with SPSS software (version 15.0 for windows, Chicago, IL, USA). Means, standard deviations (SDs) and percentages were used to describe continuous and categorical data, respectively. The student's t-test, for normally distributed data, and Mann-Whitney test, for nonnormally distributed ones, were used to analyze the differences of continuous variables between two groups while the Chi-Square test was used for categorical data. The 2-tailed p-value less than 0.05 was considered to be statistically significant. The study was approved by the Ethics Committee of Imam Khomeini Hospital.
Results
This study included 114 multiparous women without previous history of GDM or overt diabetes mellitus with first diagnosis of GDM in the current pregnancy and 113 control subjects without any history of diabetes. The mean age of the test group was 31.39±5.56 years (mean±SD) while the mean age of control group was 29.2±5.39 years. We found that risk for GDM increased significantly with increase in maternal age and in women of 26 years and older who had a 2-fold increase in risk for GDM in comparison with those who were younger (OR=2.1, p=0.028, Table 1 ).
We assessed the relationship between the birth weight of previous neonate and GDM. The difference between weight of previous neonate in the test (3674±814 g) and control (3080±568 g) groups was statistically significant (p<0.001). Women whose previous neonates weighted more than 3800 g were at higher risk of GDM (OR=9.6, p<0.001, Table 1 ). The difference between number of pregnancies as well as parity in GDM (3.07±1.22 and 1.5±0.96 respectively) and control subjects (2.88±1.38 and 1.36±1.18 respectively) did not reach the significance threshold (p=0.10 and p=0.083 respectively, Table 1 ).
The prevalence of previous fetal and neonatal deaths compared between GDM patients (12.3% and 3.5% respectively) and healthy controls (8% and 6.2% respectively) were not statistically significant (p=0.25 and 0.2 respectively, Table 1 ). We did not find any significant association between the number of previous abortions and GDM in the test (0.57±0.96) and control groups (0.53±0.94) in our study (p=0.66, Table 1 ). We also assessed the number of preterm birth in GDM women (0.25±0.53) and healthy controls (0.17±0.49) while the difference between the groups was of borderline statistical significance (p=0.055, Table 1 ).
Furthermore, we evaluated the association between hypothyroidism as well as chronic hypertension with GDM. Women with history of hypothyroidism or chronic hypertension were more prone to get GDM (OR=5.3, p=0.018 and OR=4.4, p=0.002 respectively, Table 1 ).
Discussion
Considering that GDM can complicate the maternal and fetal outcomes of pregnancy and can progress to overt diabetes, we tried to assess risk factors which can be used to predict the occurrence of this disease. Also a lot of studies have assessed common risk factors of GDM patients and their pregnancy outcomes, to our knowledge, there are few studies focusing on the previous obstetric and medical history of GDM patients. In this study, we evaluated the previous obstetric and medical history of multiparous women without a history of overt diabetes or GDM.
Our results showed that the risk of GDM rises as the maternal age increases. Women of 26 years and older had a 2-fold increase in risk for GDM (OR=2.1, p=0.028). Different studies have reported different age threshold (25-40 years old) for increased risk of GDM. 5, 6, [14] [15] [16] [17] [18] [19] [20] Previous studies have reported that macrosomia, birth weight equal or more than 4000 or 4500 gram in previous pregnancies, is a risk factor for GDM. 5, 6, 15 Here we assessed the relation between the birth weight of previous neonate with the risk of GDM and found that women having a previous neonate with birth weight greater than 3800 gram were at increased risk for GDM (OR=9.6, p<0.001). Our results in Iranian women in the present study showed that not only having a history of fetal macrosomia increases the risk of GDM, but also those women who had a neonate with birth weight equal or more than 3800 gram were at risk for this disease. There is evidence showing that significant racial and ethnic variations exist among women with GDM for access to and use of health care, presence of risk factors, and perceptions of health.
21 So the aforementioned results may be due In our study, the number of pregnancies as well as parity did not have any significant association with GDM, which is consistent with other studies. 5, 22 Roman et al. assessed the obstetric and neonatal outcomes in grand multiparity. Although they found that grand multipara had a higher rate of insulindependent gestational diabetes, after doing conditional logistic regression, it was not an independent predictor of insulin-dependent gestational diabetes mellitus. 23 But in another study, it has been shown that grand multiparity was associated with an increased risk of diabetes. 24 Some studies have shown that the fetuses whose mothers have experienced gestational diabetes mellitus are at increased risk for macrosomia and being large for gestational age which put them in the risk of birth trauma, shoulder dystocia, neonatal hypoglycemia and neonatal death. [25] [26] [27] [28] [29] [30] We wondered if women with previous history of fetal or neonatal death are at increased risk of GDM. Although some results showed that history of prior neonatal death is a risk factor for GDM, 31 we did not find any association between fetal or neonatal death and GDM, as the difference between the mean of previous fetal or neonatal deaths in test and control groups did not reach the significant threshold (p=0.25 and p=0.20 respectively).
A study by Khooshideh et al. has reported that recurrent miscarriage is a risk factor for GDM. 5 In 1991, Hughes and colleagues conducted a study on 88 women with 3 or more miscarriages and stated that GDM and chronic hypertension is more frequent comparing with the control group. 32 In our study however, we could not find any significant relationship between abortion number and GDM (p=0.66). An explanation for this result could be that those studies were limited to just recurrent or more than three miscarriages but we considered all kinds of abortions in our study.
Several researchers reported that a woman's own birth weight is inversely associated with her risk of gestational diabetes. [33] [34] [35] However, others proposed the need for further work to confirm these results. 36 The fetuses of women affected with GDM are at increased risk of preterm birth. 31, 37, 38 In this study however, we assessed whether women having previous history of preterm birth pregnancy are at increased risk for GDM. Although in our study the association of preterm birth and GDM was of borderline significance (p=0.055), these women may be at risk for GDM in later life.
Women with type 1 diabetes are at increased risk for thyroid diseases, 39 but it is not clear whether gestational diabetes patients are also susceptible. Amati et al. studied the effect of thyroid hormone status on insulin sensitivity and physical fitness after weight loss and exercise training and reported that these factors were improved in euthyroid but not in subclinical hypothyroid subjects. 40 In addition, it has been shown that subclinical hypothyroidism is associated with insulin resistance in patients with rheumatoid arthritis. 41 A study conducted by Velija-Asimi and associates on patients with subclinical hypothyroidism showed that treatment of this disease could decrease the levels of fasting insulin and fasting and postprandial glucose. 42 Also, the role of insulin resistance in gestational diabetes is reviewed by Mastrogiannis et al. 43 While insulin secretion is increased in normal pregnant women during pregnancy, gestational diabetes patients do not get this response. 44 Moreover, insulin sensitivity is decreased in these patients compared to healthy subjects. 45 All these evidences show that there may be a link between hypothyroidism and gestational diabetes.
In 2009, Torus et al. assesses the serum antioxidant levels in patients with subclinical and overt hypothyroidism and found that malondialdehyde, a lipid peroxidation marker, is increased in these patients compared with healthy subjects. 39 Similar results were reported elsewhere. 46 Chen and Scholl reviewed the role of oxidative stress in pregnancy and gestational diabetes mellitus. 47 Evidences showed that as oxidative stress increases and antioxidation defenses decrease, the secretion and action of insulin impair. 48 So it seems that the increase in oxidative stress or decrease in anti-oxidative system in hypothyroidism may interfere with insulin function.
There are evidences that physical activity could decrease the risk of gestational diabetes. 49 Besides, it has been shown that patients suffering from hypothyroidism are more prone to depression, 50 due to changes in catecholamine system of hypothalamuspituitary-thyroid axis and brain serotonergic pathways, 51 which could limit their physical activity and increase the risk of gestational diabetes.
In a recent study by Liang et al., female mice were fed with high saturated fat diet one month before conception and during gestation to develop a mouse model of gestational diabetes. The test group devel-oped more insulin resistance, lipid peroxidation and oxidation damage, features of gestational diabetes model than controls. 52 Comparing with non diabetics, women with gestational diabetes had higher serum level of triglyceride, as was reported by Enquobahrie and colleagues that each 20 mg/dl increase in TG was associated with a 10% increase in GDM risk. 53 Another study showed that LDL and triglyceride levels increased in gestational diabetes women. 54 Also, the levels of low density lipoproteins (LDL) in patients with gestational diabetes were evaluated by Rizzo et al. In comparison with the control group, women with gestational diabetes had higher LDL levels. 55 Some studies have demonstrated that total cholesterol, LDL and triglycerides are increased in patients with hypothyroidism and treating these patients can decrease their levels. 56, 57 The reason is that in hypothyroidism, the LDL receptors decrease and LDL accumulates in the serum. 58 Besides, thyroid hormones enhance the activity of lipoprotein lipase, which lowers the levels of triglycerides. 59 So in hypothyroidism, the triglycerides increase in serum and consequently, it can be a risk factor for developing gestational diabetes.
It has been shown that hypothyroidism is a risk factor for obesity. 60, 61 In addition, lots of researchers reported that the risk of gestational diabetes increases as the BMI rise.
4,62 As a consequence, hypothyroid patients are at increased risk of getting gestational diabetes.
Our results showed that chronic hypertension is more prevalent in GDM women (p=0.002), which raises the possibility that hypertension is a predictor of GDM. Other studies reported similar results. 6, 63, 64 Caruso et al. reported that insulin sensitivity of women with chronic hypertension and GDM was approximately twofold lower than those with GDM only and they concluded that blood pressure is a strong predictor of insulin resistance. 65 Another study has reported the same results. 64 Metabolic syndrome is characterized by presence of hypertension, insulin resistance, glucose intolerance, dyslipidemia and central obesity. 66 Besides, it is regarded that chronic insulin resistance is central component of GDM. 67 According to aforementioned data, we conclude that women with gestational diabetes have an insulin resistance background. Some features of this background, such as hypertension show themselves earlier which can predict the occurrence of other elements, such as GDM, in later life. In addition to the fact that gestational diabetes is associated with hypertensive disorders, it has shown that subclinical hypothyroidism could lead to hypertension, mainly high diastolic pressure. 68 So there is one possibility that the association of gestational diabetes with hypertension, at least in part, is due to the more prevalence of hypothyroidism in gestational diabetes women.
In this study, we showed that maternal age, the birth weight of previous neonate, hypothyroidism, chronic hypertension and probably previous history of having a preterm birth are associated with GDM. Results of such studies can be used to predict the chance of GDM in healthy women and adopting preventive strategies in at-risk population. Although some studies suggest that universal screening appears to be the most reliable method of diagnosing GDM, 19 in 2009, the American Diabetes Association stated that screening a low-risk group of pregnant women is probably not cost-effective. 69 Therefore, identifying new risk factors for GDM can increase the sensitivity for selection of those women benefits from oral glucose tolerance test. Surely, more studies are needed to confirm our results. 
